Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy

Oncolytic viral immunotherapies are agents which can directly kill tumor cells and activate an immune response. Oncolytic viruses (OVs) range from native/unmodified viruses to genetically modified, attenuated viruses with the capacity to preferentially replicate in and kill tumors, leaving normal ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Robilotti, Elizabeth, Zeitouni, Nathalie C., Orloff, Marlana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546393/
https://www.ncbi.nlm.nih.gov/pubmed/37795219
http://dx.doi.org/10.3389/fmolb.2023.1178382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546393/
https://www.ncbi.nlm.nih.gov/pubmed/37795219
http://dx.doi.org/10.3389/fmolb.2023.1178382

Ejemplares similares